TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 5 | 0 | 1 | 0 | -1 | 13 | 22 | 7 |
| S | %wins | 60 | 60 | 60 | 60 | 0 | 0 | 40 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/4/13 16:18 | 5/31/13 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Cazala Beatrice J | NY | O | EVP Comm | S | -4,290 | 47.00 | 33 | -91 | -34 | 177 | D | 79 | 48 | 48 | 30 | 13 | 16 | 3 | 2 | -1 | 1 | -5 | -10 | 11 | 8 |
6/3/13 17:56 | 5/30/13 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Cazala Beatrice J | NY | O | EVP Comm | S | -1,034 | 47.00 | 33 | -22 | -8 | 268 | D | 75 | 43 | 43 | 25 | 12 | 14 | 4 | -4 | -2 | 0 | -6 | -12 | 11 | 6 |
5/23/13 17:20 | 5/23/13 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Cazala Beatrice J | NY | O | EVP Comm | S.d | -4,511 | 46.99 | 33 | -96 | -25 | 290 | D | 76 | 47 | 48 | 28 | 12 | 16 | 13 | 7 | 1 | 0 | -3 | -12 | 12 | 7 |
3/11/13 16:47 | 3/7/13 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Cazala Beatrice J | NY | O | EVP Comm | S.d | -3,150 | 37.61 | 33 | -84 | -24 | 270 | D | 55 | 20 | 15 | 15 | 2 | 2 | 1 | 0 | 2 | 4 | 10 | 28 | 14 | 54 |
8/14/12 16:14 | 8/10/12 | BMY | Bristol Myers Squibb Co | DE | Health | Drug | Pharmaceutical Preparations | Cazala Beatrice J | NY | O | EVP Comm | S.d | -4,565 | 31.79 | 33 | -144 | -41 | 209 | D | 31 | 17 | 1 | -3 | -12 | -9 | -3 | -2 | 0 | 0 | 6 | 1 | 18 | 37 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |